The Business Research Company’s report on the Self-Injections Market provides insights into the global market size, growth rate, regional distribution, competitive landscape, key segments, emerging trends, and strategic opportunities.
#How have key drivers contributed to the rapid growth of the self-injections market?
The growing number of diabetic patients is expected to propel the growth of the self-injections market going forward. Diabetes refers to a condition where the pancreas, a human organ that produces insulin, produce less than an adequate level of insulin which leads to the breakdown of blood sugars and causes serious health conditions like heart disease, vision loss, and kidney diseases. Self-injections can be used by diabetic patients for injecting insulin and other medications which help maintain optimum blood sugar levels and block any excess blood sugars at any given point of time without the help of a medical professional. For instance, in March 2022, according to the IDF Diabetes Atlas, a Belgium-based global resource providing comprehensive data and insights on diabetes prevalence, treatment, and care worldwide, the global prevalence of diabetes is projected to increase from 643 million in 2030 to 783 million by 2045, an addition of 140 million cases. Currently, 537 million adults live with diabetes, with over 75% in low- and middle-income countries. Therefore, the growing number of diabetic patients is driving the growth of the self-injections market.
Access Your Free Sample of the Global Self-Injections Market Report – Get Insights Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=8235&type=smp
How has the self-injections market size evolved, and what are the latest forecasts for its expansion?
The self-injections market size has grown strongly in recent years. It will grow from $9.69 billion in 2024 to $10.3 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to rising chronic diseases, improved patient empowerment, regulatory support, preference for home healthcare, cost-effectiveness.
The self-injections market size is expected to see strong growth in the next few years. It will grow to $14.13 billion in 2029 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to pandemic impact and remote treatment, expansion into emerging markets, patient-centric healthcare, advantages in drug delivery, personalized medicine trends. Major trends in the forecast period include smart technology integration, rise in biologics usage, miniaturization and wearable devices, enhanced safety features, adoption of autoinjectors.
Gain Exclusive Market Insights—Customize Your Research Report Today For Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=8235&type=smp
Which major companies dominate the self-injections market?
Major companies operating in the self-injections market are AbbVie Inc., Antares Pharma Inc., Baxter International Inc., Bayer AG, Becton Dickinson and Company, Bristol-Myers Squibb Company, Credence MedSystems Inc., Dali Medical Devices Ltd., Eli Lilly and Company, Enable Injections Inc., Gerresheimer AG, Insulet Corporation, Merck & Co. Inc., Owen Mumford Limited, Pfizer Inc., PharmaJet Inc., Recipharm AB, Schott AG, SHL Group Limited, Terumo Corporation, West Pharmaceutical Services Inc., Wilhelm Haselmeier GmbH & Co. KG, Ypsomed Holding AG, APTAR PHARMA INDIA PVT LTD, Bespak Europe Ltd., Bioject Medical Technologies Inc., Catalent Inc., Crossject SA, Injex Pharma AG, Medeca Pharma AB, Medimop Medical Projects Ltd., Mylan N.V., Nemera Development S.A., Noble Medical Inc.
What trends will shape the future of the self-healing grid market?
Major companies operating in the self-injections market are developing new solutions for insulin injections to gain a competitive edge in the market. For instance, in September 2022, Terumo Corporation, a Japan-based medical device company launched FineGlide, a Sterile Pen Needle designed for patients requiring regular insulin injections or other self-medication. Compatible with most commonly used pen devices in India, FineGlide prioritizes patient comfort, aiming to enhance drug compliance. FineGlide boasts a 3-bevel super sharp needle with a high-grade silicone surface, ensuring gentleness and comfort for patients. It incorporates Thin Wall Technology for improved flow rate and reduced injection force.
Which region dominates the self-injections market, and what factors contribute to its leadership?
North America was the largest region in the self-injections market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the self-injections market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Order Your Report Now For Swift Delivery
https://www.thebusinessresearchcompany.com/report/self-injections-global-market-report
How is the self-injections market segmented, and which segment holds the largest share?
The self-injections market covered in this report is segmented –
1) By Type: Devices, Formulations
2) By Route Of Administration: Skin, Circulatory Or Musculoskeletal, Organs, Central Nervous System
3) By Dosage: Single Dose, Multi Dose
4) By Application: Autoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy, Other Applications
5) By Distribution Channel: Hospitals Pharmacies, Clinics, Chemist, Online Pharmacies
Subsegments:
1) By Devices: Pre-Filled Syringes, Auto-Injectors, Microneedle Devices, Wearable Injectors
2) By Formulations: Biologics, Vaccines, Small Molecules, Combination Products
Purchase The Exclusive Report Now To Unlock Valuable Market Insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8235
How is the self-injections market defined, and what are its core characteristics?
Self-injection refers to a device used for the act of injecting oneself. Self-injections enable patients and users to administer medicines and drugs that need to be injected into them by themselves without the need for a physician or a medical professional.
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
https://thebusinessresearchcompany.com/
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
